How Much Weight Did You Lose on Zepbound?

Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, the active ingredient in Zepbound, produced an average weight loss of 21% in the SURMOUNT-1 trial—nearly double the results seen with older GLP-1 medications. But individual outcomes vary significantly based on genetics, lifestyle, and how your body responds to the dual GLP-1 and GIP receptor activation.

What Weight Loss Did Zepbound Patients Actually Experience?

The SURMOUNT clinical trial program enrolled over 4,500 people with obesity and followed their progress for 68 weeks. At the highest approved dose, participants lost an average of 21.4% of their starting body weight—a loss of roughly 52 pounds for someone starting at 240 pounds. This exceeded results from semaglutide trials, where average weight loss ranged from 15% to 18% at maximum dose.

Not everyone achieved the same result. Some participants lost as little as 5% of body weight, while top responders shed 35% or more. Women, younger patients, and those with baseline metabolic flexibility showed better outcomes in subgroup analyses. Your genetics play a measurable role: variants in the GLP1R and GIPR genes correlate with response strength, which is why personalized testing can help predict your potential weight loss trajectory.

Weight loss typically follows a predictable curve. Most patients see meaningful progress in months 1–3, with continued decline through month 4–6. Plateau occurs around month 4–5 for many users, though increasing the dose can restart progression if your metabolism adapts.

How Tirzepatide Outperforms Other GLP-1 Medications

Tirzepatide activates two receptor pathways instead of one: GLP-1 and GIP. This dual mechanism suppresses appetite more aggressively than semaglutide (GLP-1 only) and produces faster gastric emptying and improved insulin sensitivity. In head-to-head comparisons, tirzepatide users lost 3–5 more percentage points of body weight than semaglutide users over the same timeframe.

The GIP pathway is particularly important because it regulates blood sugar and appetite through a separate neural circuit. People with certain FTO and MC4R genetic variants show enhanced response to dual-pathway activation, making tirzepatide a smarter choice for their biology. PlexusDx's Precision Peptide Genetic Test maps these variants to help you understand whether tirzepatide aligns with your genetic predispositions for weight loss.

Factors That Influence Your Personal Weight Loss Results

Starting weight and metabolic rate determine your ceiling for weight loss. Someone starting at 300 pounds may lose 60+ pounds, while someone at 200 pounds might lose 25–35. Baseline insulin resistance amplifies GLP-1 response because these medications improve insulin sensitivity, which helps regulate hunger hormones more effectively in resistant patients.

Genetics account for 40–60% of weight loss variance in clinical trials. The rs6923761 variant in the GLP1R gene, the rs1800437 variant in GIPR, and the rs9939609 variant in FTO each influence how efficiently your body processes appetite-suppressing signals. Behavioral consistency matters equally: patients who combine medication with structured eating patterns and regular movement consistently outperform those who rely on the drug alone.

Age, sex, and previous weight loss attempts also shape outcomes. Younger patients (under 50) and women respond slightly faster in the first 8–12 weeks. Prior experience with other weight loss methods sometimes predicts better medication adherence and realistic expectations.

PlexusDx Tirzepatide: Access and Personalization Without the Premium Price

PlexusDx compounded tirzepatide injections start at $249 per month—substantially lower than brand-name Zepbound ($1,100–$1,400 per month). Your dose may need to go up. Your price won't. PlexusDx charges one flat monthly rate across all three commitment tiers, so dose escalation never triggers a price increase as you move from starter doses (2.5 mg) toward therapeutic range (7.5 mg+).

All medications ship from licensed 503A compounding pharmacies certified for injectable sterile preparation. PlexusDx requires no insurance, membership fee, or subscription lock-in, making treatment accessible to anyone nationwide across all 50 states. HSA and FSA accounts cover tirzepatide injections, effectively lowering your out-of-pocket cost if you hold these tax-advantaged accounts.

The Precision Peptide Genetic Test ($99 add-on after your first month) sequences your GLP1R, GIPR, FTO, and MC4R variants to forecast your expected weight loss range and identify whether tirzepatide or dual-compound therapy (GLP-Squared) matches your biology. This data-driven approach personalizes your protocol without guesswork.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight do most people lose on tirzepatide in the first month?

Most users see 2–4 pounds of weight loss in the first 4 weeks as appetite suppression kicks in. The dose typically starts low (2.5 mg) to allow your GI tract to adapt. Meaningful acceleration occurs by week 8–12 once you reach a therapeutic dose (5–7.5 mg), with an average of 0.5–1 pound per week sustained through month 6.

Is tirzepatide's 21% weight loss average guaranteed?

No. The 21% figure represents the mean across the SURMOUNT trial; individual results ranged from 5% to 35%. Your outcome depends on genetics, starting weight, diet quality, physical activity, and adherence. PlexusDx's Precision Peptide Genetic Test identifies your GLP1R and GIPR variants to estimate your personalized weight loss potential.

Why is PlexusDx tirzepatide more affordable than Zepbound?

PlexusDx sources compounded tirzepatide from licensed 503A pharmacies, which bypass the brand-name markup and extensive marketing costs. Starting at $249 per month with no flat per-compound pricing changes, PlexusDx makes tirzepatide accessible without insurance. Patients can also apply HSA/FSA funds to reduce costs further.

Can I expect weight loss to continue after month 6?

Most patients plateau around month 4–6 at their current dose because appetite suppression and metabolism reach equilibrium. Increasing your tirzepatide dose often restarts weight loss progression. After month 12, many users maintain their loss with the same dose; others require modest increases if weight drift occurs.

How do genetic variants affect my tirzepatide weight loss?

Variants in GLP1R, GIPR, FTO, and MC4R genes influence receptor sensitivity and appetite regulation. The rs6923761 GLP1R variant correlates with stronger GLP-1 response; rs1800437 GIPR variants predict GIP pathway effectiveness. PlexusDx's $99 Precision Peptide Genetic Test maps these 14 pathways across 150+ insights to personalize your tirzepatide protocol.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Zepbound For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.